在治疗纤维肌痛时,FIQR严重性类别和症状是否区分持续,间歇和非阿片类药物使用者?
Andrea R Pfalzgraf1, Ronald Friend2, Kimberly Dupree Jones3
1From the National University of Natural Medicine, Helfgott Research Institute, Portland, OR.
概括
在纤维肌痛中,阿片类药物的使用很常见,有45%的患者使用它们. 通过修订的纤维肌痛影响问卷 (FIQR) 测量较高的症状严重程度与增加的阿片类药物使用相关.
科学领域:
- 类风湿病学 类风湿病学
- 疼痛管理 疼痛管理
- 患者报告的结果
背景情况:
- 在纤维肌痛患者中,阿片类药物的使用在症状管理方面很普遍.
- 了解阿片类药物使用模式和相关的患者体验至关重要.
研究的目的:
- 评估纤维肌痛中阿片类药物使用率 (连续,间歇,非使用者).
- 评估修订的纤维肌痛影响问卷 (FIQR) 以区分阿片类药物使用和症状严重程度.
- 调查患者报告的与纤维肌痛治疗相关的耻辱和失效情况.
主要方法:
- 这是一项涉及1,105名参与者的横截面观察性研究.
- 在线调查方法采用经过验证的纤维肌痛和失效量表.
- 对人口数据和阿片类药物使用模式的分析.
主要成果:
- 45%的纤维肌痛患者报告使用阿片类药物 (27%持续使用,18%间歇使用).
- 该FIQR明确区分了阿片类药物使用者 (更严重的症状) 和非使用者 (更轻微的症状) (p < .0001).
- 与间歇性或非使用者相比,持续使用阿片类药物的人报告说,与日常活动有显著的困难,以及较高的症状负担.
结论:
- 在纤维肌痛中使用阿片类药物很常见,并且与FIQR指出的症状严重程度直接相关.
- 建议采取多学科干预措施,解决日常功能,情感福祉,目标实现和减少耻辱感.
- 对非阿片类药物管理策略和患者支持的进一步研究是有必要的.
相关概念视频
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
307
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
307
01:25Analgesia and Pain Management
632
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
632
01:17Drugs for Treatment of Diarrhea-Predominant IBS
183
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
183
01:26Patterns of Fever
2.6K
Before understanding the types and patterns of fever, it is essential to know its phases.
2.6K
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
115
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
115
01:25Drug Classes and Categories
2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K